Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $980M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPDR SERIES TRUST | 825,000 | $105M | 10.8% | — | — | Put | 78464A950 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,876,407 | $57.9M | 5.9% | $12.52 | +23.7% | COM | 483497103 |
| DNTH | DIANTHUS THERAPEUTICS INC | 654,746 | $54.95M | 5.6% | $26.43 | +80.0% | COM | 252828108 |
| COGT | COGENT BIOSCIENCES INC | 1,314,189 | $50.58M | 5.2% | $18.51 | +101.9% | COM | 19240Q201 |
| CELC | CELCUITY INC | 357,903 | $40.85M | 4.2% | $72.23 | +48.8% | COM | 15102K100 |
| IMNM | IMMUNOME INC | 1,850,278 | $40.47M | 4.1% | $19.71 | +17.0% | COM | 45257U108 |
| KOD | KODIAK SCIENCES INC | 991,930 | $37.81M | 3.9% | $7.38 | +244.7% | COM | 50015M109 |
| NUVL | NUVALENT INC | 354,914 | $36.36M | 3.7% | $77.35 | +34.0% | COM | 670703107 |
| ABVX | ABIVAX SA | 302,530 | $33.69M | 3.4% | $84.90 | — | SPONSORED ADS | 00370M103 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 2,002,040 | $32.93M | 3.4% | $14.13 | +46.2% | COM | 61225M102 |
| ERAS | ERASCA INC | 1,851,812 | $29.96M | 3.1% | $4.46 | +124.9% | COM | 29479A108 |
| ASND | ASCENDIS PHARMA A/S | 124,658 | $28.51M | 2.9% | $196.77 | — | SPONSORED ADR | 04351P101 |
| URGN | UROGEN PHARMA LTD | 1,503,045 | $27.02M | 2.8% | $13.27 | +57.0% | COM | M96088105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 306,000 | $26.61M | 2.7% | $74.67 | +37.7% | COM | 76243J105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 71,552 | $23.05M | 2.4% | $100.25 | +211.0% | COM NEW | 74006W207 |
| ZBIO | ZENAS BIOPHARMA INC | 1,135,935 | $22.21M | 2.3% | $21.89 | 0.0% | COM | 98937L105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 888,987 | $20.77M | 2.1% | $18.33 | +13.2% | COM | 87164F105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 466,345 | $18.52M | 1.9% | $24.95 | — | SPONSORED ADS | 152309100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 339,613 | $16.7M | 1.7% | $45.48 | 0.0% | COM | 80706P103 |
| ALKS | ALKERMES PLC | 460,314 | $16.28M | 1.7% | $32.34 | 0.0% | SHS | G01767105 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,100,010 | $13.94M | 1.4% | $6.76 | +59.4% | COM | 68622P109 |
| IRON | DISC MEDICINE INC | 196,028 | $12.53M | 1.3% | $74.04 | 0.0% | COM | 254604101 |
| HLXC | HELIX ACQUISITION CORP III | 1,208,986 | $12.28M | 1.3% | $10.16 | — | USD CL A ORD SHS | G4444S107 |
| XENE | XENON PHARMACEUTICALS INC | 197,759 | $11.5M | 1.2% | $41.98 | 0.0% | COM | 98420N105 |
| CGON | CG ONCOLOGY INC | 166,349 | $11.26M | 1.1% | $24.86 | +110.9% | COM | 156944100 |
| IMVT | IMMUNOVANT INC | 414,236 | $10.29M | 1.1% | $26.26 | 0.0% | COM | 45258J102 |
| SYRE | SPYRE THERAPEUTICS INC | 186,618 | $9.413M | 1.0% | $26.13 | +32.2% | COM NEW | 00773J202 |
| BIIB | BIOGEN INC | 50,967 | $9.344M | 1.0% | $135.17 | +35.6% | COM | 09062X103 |
| GH | GUARDANT HEALTH INC | 98,514 | $9.1M | 0.9% | $90.66 | +18.5% | COM | 40131M109 |
| PCVX | VAXCYTE INC | 144,981 | $8.425M | 0.9% | $32.81 | +60.8% | COM | 92243G108 |
| — | UNIQURE NV | 500,000 | $8.175M | 0.8% | — | — | Call | N90064901 |
| SVRA | SAVARA INC | 1,430,982 | $7.813M | 0.8% | $5.69 | 0.0% | COM | 805111101 |
| BNTC | BENITEC BIOPHARMA INC | 717,725 | $7.644M | 0.8% | $13.20 | -10.8% | COM NEW | 08205P209 |
| — | SYNDAX PHARMACEUTICALS INC | 320,000 | $7.475M | 0.8% | — | — | Call | 87164F905 |
| ORKA | ORUKA THERAPEUTICS INC | 150,908 | $7.402M | 0.8% | $32.45 | 0.0% | COM | 687604108 |
| CGEN | COMPUGEN LTD | 3,315,845 | $7.063M | 0.7% | $1.61 | +14.1% | ORD | M25722105 |
| — | CELCUITY INC | 54,500 | $6.221M | 0.6% | — | — | Call | 15102K900 |
| TRVI | TREVI THERAPEUTICS INC | 511,127 | $6.098M | 0.6% | $3.55 | +208.1% | COM | 89532M101 |
| INSM | INSMED INC | 35,850 | $5.862M | 0.6% | $56.86 | +179.7% | COM PAR $.01 | 457669307 |
| VCYT | VERACYTE INC | 179,700 | $5.788M | 0.6% | $34.23 | +14.9% | COM | 92337F107 |
| CERS | CERUS CORP | 3,176,547 | $5.781M | 0.6% | $3.16 | -25.8% | COM | 157085101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 178,378 | $5.658M | 0.6% | $27.17 | -6.5% | COM NEW | 15117B202 |
| CCCC | C4 THERAPEUTICS INC | 1,911,785 | $5.028M | 0.5% | $2.40 | -13.0% | COM STK | 12529R107 |
| CYTK | CYTOKINETICS INC | 71,203 | $4.693M | 0.5% | $64.44 | 0.0% | COM NEW | 23282W605 |
| CLYM | CLIMB BIO INC | 684,908 | $4.692M | 0.5% | $5.00 | 0.0% | COM | 28658R106 |
| CMPX | COMPASS THERAPEUTICS INC | 859,049 | $4.544M | 0.5% | $2.86 | +109.9% | COM | 20454B104 |
| SRZN | SURROZEN INC | 144,255 | $4.202M | 0.4% | $16.18 | +37.4% | COM NEW | 86889P208 |
| CTNM | CONTINEUM THERAPEUTICS INC | 301,729 | $3.941M | 0.4% | $9.60 | +39.1% | CL A | 21217B100 |
| ZURA | ZURA BIO LTD | 560,651 | $3.336M | 0.3% | $5.88 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| FULC | FULCRUM THERAPEUTICS INC | 419,949 | $3.221M | 0.3% | $10.19 | +1.8% | COM | 359616109 |
| — | FULCRUM THERAPEUTICS INC | 391,900 | $3.006M | 0.3% | — | — | Call | 359616909 |
| ABEO | ABEONA THERAPEUTICS INC | 648,942 | $2.907M | 0.3% | $5.72 | -9.7% | COM NEW | 00289Y206 |
| CAMP | CAMP4 THERAPEUTICS CORP | 653,594 | $2.882M | 0.3% | $4.67 | 0.0% | COM | 13463J101 |
| ANNX | ANNEXON INC | 496,461 | $2.75M | 0.3% | $5.75 | 0.0% | COM | 03589W102 |
| ELUT | ELUTIA INC | 2,498,020 | $2.623M | 0.3% | $3.14 | -70.3% | CL A COM | 05479K106 |
| CBIO | CRESCENT BIOPHARMA INC. | 130,500 | $2.397M | 0.2% | $11.06 | 0.0% | COM | G2545C104 |
| MNPR | MONOPAR THERAPEUTICS INC | 43,488 | $2.383M | 0.2% | $62.79 | 0.0% | COM NEW | 61023L207 |
| OVID | OVID THERAPEUTICS INC | 1,000,000 | $2.22M | 0.2% | $1.60 | 0.0% | COM | 690469101 |
| NXTC | NEXTCURE INC | 176,057 | $1.88M | 0.2% | $10.36 | +21.4% | COM NEW | 65343E207 |
| CMPS | COMPASS PATHWAYS PLC | 300,000 | $1.659M | 0.2% | $5.53 | — | SPONSORED ADS | 20451W101 |
| NMRA | NEUMORA THERAPEUTICS INC. | 818,156 | $1.595M | 0.2% | $2.46 | 0.0% | COM | 640979100 |
| SION | SIONNA THERAPEUTICS INC | 39,417 | $1.58M | 0.2% | $15.09 | +160.1% | COM | 829401108 |
| TELA | TELA BIO INC | 2,259,312 | $1.401M | 0.1% | $4.46 | -79.3% | COM | 872381108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 42,615 | $1.342M | 0.1% | $20.18 | +39.6% | COM | 28036F105 |
| REPL | REPLIMUNE GROUP INC | 171,936 | $1.315M | 0.1% | $7.81 | 0.0% | COM | 76029N106 |
| GENB | GENERATE BIOMEDICINES INC | 100,000 | $1.25M | 0.1% | $12.50 | — | COM SHS | 370920100 |
| — | COMPASS THERAPEUTICS INC | 172,400 | $912K | 0.1% | — | — | Call | 20454B904 |
| RADX | RADIOPHARM THERANOSTICS LTD | 187,406 | $806K | 0.1% | $4.49 | — | SPONSORED ADS | 75041J101 |
| GUTS | FRACTYL HEALTH INC | 1,701,625 | $779K | 0.1% | $1.40 | -14.2% | COM | 35168W103 |
| IBIO | IBIO INC | 226,000 | $429K | 0.0% | $1.87 | +23.8% | COM NEW | 451033708 |
| ADGM | ADAGIO MED HLDGS INC | 251,972 | $290K | 0.0% | $1.19 | -17.3% | COM | 00534B100 |
| AARD | AARDVARK THERAPEUTICS INC | 33,684 | $127K | 0.0% | $10.73 | +26.5% | COM | 002942100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 104,828 | $2,159 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |